DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
People / Cindy Xiong
Cindy Xiong
Roles
1 current, 0 past
Investments attributed to this person
1
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics | Series B · $89.0M · Series B | Foresite Capital | confirmed | Mar 26, 2026 | Fact prnewswire.com |
Board seats and vehicles
1 boards, 0 vehicles
- Slate Medicines, Inc. Director Mar 11, 2026 Fact
Timeline
0
No dated event.